MVP Journal of Medical Sciences

Open Access Open Access  Restricted Access Subscription Access

Gaucher's Disease - A Case Report


Affiliations
  • Dr. Vasantrao Pawar Medical College Hospital and Research Center, Department of Pathology, Nashik, India
  • Shri Guru Teg Bahadur Hospital, Ludhiana, India
 

Gaucher's Disease (GD) is an autosomal recessive systemic lysosomal storage disorder which is characterized by glucocerebroside deposition in cells of the macrophage-monocyte system as a result of a deficiency in lysosomal P-glycosidase (glucocerebrosidase). GD is a rare genetic disorder. It is the most common amongst the lysosomal storage disorders. GD has been categorised into three types based on the presence of central nervous involvement1. Type 1 is a non-neuronopathic form that presents in childhood or early adulthood. Type 2 is acute neuronopathic form that presents in childhood. It progresses rapidly and is fatal. Type 3 is chronic non-neuronopathic form that presents in childhood but is slowly progressive. Here we describe a case of a three and a half year old male child in whom a diagnosis of Gaucher's disease was made based on bone marrow biopsy and later confirmed by glucocerebrosidase levels estimation.

Keywords

Gaucher’s Disease, Glucocerebroside.
Font Size

User
Notifications

  • Bohra V, Nair V. Gaucher’s disease. Indian J Endocr Metab. 2011; 15:182-6.

  • Patel AL, Shaikh WA, Khobragade AK, Soni HG, Joshi AS, Sahasrabudhe GS, Chole PV. Gaucher’s Disease. The Journal of the Association of Physicians of India. 2009 May; 57:410-1.

  • Ahmadieh, et al. Journal of Medical Case Reports. 2014; 8:360.

  • Nagral A, Mewawalla P, Jagadeesh S, et al. Recombinant Macrophage Targeted Enzyme Replacement Therapy for Gaucher Disease in India. Indian Pediatrics. 2011; 48:779- 84.

  • Ash Image Bank. Waldenstrom macroglobulinemia with pseudo-Gaucher cells. Blood. 2010 Nov; 116(18):3388.

  • Beutler E, Grabowski GA. Glucosylceramide lipidosis-Gaucher disease. The metabolic and molecular bases of inherited diseases. 8th ed. New York: Mc Graw -Hill; 2001. p. 3635-68.

  • Neelaveni N, Anunayi J, Raju YR, et al. Pediatric Non-neuronopathic Gaucher Disease- A Case Report. Sch J Med Case Rep. 2014; 2(2):96-9.

  • Mc Eachern KA, Fung J, Komarnitsky S, et al. A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease. Molecular Genetics and Metabolism. 2007 Jul; 91(3):259-67.

  • Priyani AAH. Gaucher’s Disease: a rare disease with an unusual presentation. Journal of Diagnostic Pathology. 2014; 9(1):33-6.


Abstract Views: 203

PDF Views: 85




  • Gaucher's Disease - A Case Report

Abstract Views: 203  |  PDF Views: 85

Authors

Preeti Bajaj
, India
Jyoti Kasture
, India

Abstract


Gaucher's Disease (GD) is an autosomal recessive systemic lysosomal storage disorder which is characterized by glucocerebroside deposition in cells of the macrophage-monocyte system as a result of a deficiency in lysosomal P-glycosidase (glucocerebrosidase). GD is a rare genetic disorder. It is the most common amongst the lysosomal storage disorders. GD has been categorised into three types based on the presence of central nervous involvement1. Type 1 is a non-neuronopathic form that presents in childhood or early adulthood. Type 2 is acute neuronopathic form that presents in childhood. It progresses rapidly and is fatal. Type 3 is chronic non-neuronopathic form that presents in childhood but is slowly progressive. Here we describe a case of a three and a half year old male child in whom a diagnosis of Gaucher's disease was made based on bone marrow biopsy and later confirmed by glucocerebrosidase levels estimation.

Keywords


Gaucher’s Disease, Glucocerebroside.

References





DOI: https://doi.org/10.18311/mvpjms%2F2015%2Fv2%2Fi2%2F788